Clinical Trial Update: Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of BCT197 in patients undergoing cardiac surgery was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• BCT197

Snippet

Sponsor: Mereo BioPharma | Conditions: Acute Kidney Injury | Phase 2 | Status: TERMINATED | Results posted: 2018-11-08